Stay updated with breaking news from Cell Line Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, ON (PRWEB) September 15, 2022 -- Chinese hamster ovary (CHO) cells have been the cell line of choice for producing most biotherapeutics. The
The global Bioprocess Technology Market is projected to reach US$ 79 billion by 2028, a 15% CAGR between 2022 and 2028.
Toronto, ON (PRWEB) August 30, 2022 -- For a monoclonal antibody-based therapeutic an important aspect of an investigational new drug (IND) application, is
ProBioGen is delighted to close a Master Service Agreement with NextPoint and initiate development and GMP manufacturing of their lead antibody candidate. ProBioGen's CHO.RiGHT® cell line development including their latest DirectedLuck® transposase and platform processes enable the development to provide a ...
Discover the latest tools and techniques to expand your research capacity with expert-led presentations